On September 8, 2022, Nova Leap Health Corp. closed the transaction. The company issued 6,814,445 common shares for gross proceeds of CAD 2,385,055.75 in the transaction. The common shares issued pursuant to the offering are subject to a hold period until January 9, 2023. The transaction included participation from insiders of the company subscribed for an aggregate of 5,600,087 common shares, owns 38.72% of the issued and outstanding common shares of the company. The company paid cash finder's fees of CAD 12,000 which was equal to 6.0% of the gross proceeds of the Offering raised through certain brokers.

The TSX Venture Exchange has accepted for filing documentation with respect to the transaction. The transaction included participation from 12 placees including total pro group involvement of one placee for 571,500 shares and total existing insider involvement for six placees for 5,600,087 shares. The company paid agents' fees of CAD 12,001.50 in the transaction.